From Sage Therapeutics to Venture Capital: Biotech’s Shifting Landscape
Cure Ventures hires executives from Sage Therapeutics, showcasing the growing interest in neuroscience startups and the potential for advancements in ...
- Latest
- Trending
Cure Ventures hires executives from Sage Therapeutics, showcasing the growing interest in neuroscience startups and the potential for advancements in ...
European startups are facing funding challenges amid a decline in foreign investment, leading to strategic shifts and a focus on ...
Clinicians who VC offers an exciting opportunity for clinicians interested in the startup and venture capital ecosystem, bridging the gap ...
Read about Foxe Capital's new venture fund, Exponent Founders Capital's $75M second fund, HSBC's Zing app, the Synapse controversy, and ...
Investing in early-stage companies in New Hampshire and across New England, Launch New Hampshire aims to develop an innovation ecosystem ...
Mauled by the markets: Venture capitalists face bleak cash prospects after investing in companies at sky-high valuations. The era of ...
Saudi Arabia solidifies its position as top destination for venture capital funding in MENA, with $1.15bn raised in December 2023. ...
In a world of uncertain markets, investors are looking beyond traditional stocks and bonds to alternative investments. Discover the options ...
Global startup funding reached its lowest point in 5 years at $285 billion in 2023, reflecting a 38% decline from ...
Silicon Valley's blindspot: Lack of diversity, equity, and inclusion hindering business success and innovation. Investment in nature-based solutions gaining traction ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.